Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06059001
Title Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC (OMO-103-02)
Acronym OMO-103-02
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Peptomyc S.L.
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.